Article Details
Retrieved on: 2021-07-07 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Libtayo® is a PD-1 blocking antibody being jointly developed and ... key disease modifying pathways with monoclonal antibodies directed at specific ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here